Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Ocean Bio-Chem (OBCI) Stock Price
News stories about Ocean Bio-Chem (NASDAQ:OBCI) have been trending somewhat positive on Sunday, Accern reports. The research group identifies negative and positive press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Ocean Bio-Chem earned a news impact score of 0.22 on Accern’s scale. Accern also assigned headlines about the company an impact score of 46.853862981584 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
Here are some of the headlines that may have impacted Accern Sentiment Analysis’s analysis:
- Ocean Bio-Chem, Inc. :OBCI-US: Earnings Analysis: Q2, 2017 By the Numbers : August 17, 2017 (finance.yahoo.com)
- Ocean Bio-Chem, Inc. (OBCI) Downgraded by TheStreet to C+ (americanbankingnews.com)
- Ocean Bio-Chem, Inc. (MM) (NASDAQ:OBCI) (ih.advfn.com)
- Ocean Bio Chem : *OCEAN BIO CHEM INC Management’s Discussion and Analysis of Financial Condition and Results of Operations 12-16 (form 10-Q) (4-traders.com)
- Ocean Bio-Chem, Inc. Reports Record Net Income of $953,000, Increase of 45% and Record Net Sales of $9.9 million for the Second Quarter (finance.yahoo.com)
Shares of Ocean Bio-Chem (NASDAQ OBCI) traded down 1.9876% during mid-day trading on Friday, reaching $3.9401. The company’s stock had a trading volume of 6,684 shares. The stock has a 50 day moving average of $4.03 and a 200-day moving average of $4.30. The stock has a market cap of $36.36 million, a P/E ratio of 10.4790 and a beta of 0.66. Ocean Bio-Chem has a one year low of $2.41 and a one year high of $5.65.
Ocean Bio-Chem (NASDAQ:OBCI) last posted its quarterly earnings data on Monday, August 14th. The company reported $0.10 earnings per share for the quarter. The business had revenue of $9.90 million for the quarter. Ocean Bio-Chem had a return on equity of 15.10% and a net margin of 8.80%.
Separately, TheStreet cut Ocean Bio-Chem from a “b-” rating to a “c+” rating in a research note on Friday, August 11th.
ILLEGAL ACTIVITY NOTICE: This piece was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another website, it was illegally stolen and republished in violation of international trademark & copyright laws. The legal version of this piece can be viewed at https://www.thecerbatgem.com/2017/08/20/somewhat-favorable-media-coverage-somewhat-unlikely-to-affect-ocean-bio-chem-obci-stock-price.html.
About Ocean Bio-Chem
Ocean Bio-Chem, Inc is engaged in the manufacturing, marketing and distribution of a range of appearance, performance and maintenance products. The Company offers its services under the Star brite and Star Tron brand names within the United States and Canada. In addition, the Company produces private label formulations of its products for various customers and provides custom blending and packaging services for these and other products.
Receive News & Stock Ratings for Ocean Bio-Chem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ocean Bio-Chem Inc. and related stocks with our FREE daily email newsletter.